Ariad Pharmaceuticals, Inc. (ARIA) Reports First Quarter 2013 Financial Results and Development Progress
5/7/2013 8:11:51 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the first quarter, including revenue from its first cancer medicine, Iclusig® (ponatinib), which was approved last December by the U.S. Food & Drug Administration. The Company also provided an update on corporate developments.
Help employers find you! Check out all the jobs and post your resume.